Rankings
▼
Calendar
NVCR Q4 2020 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q4 2020 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$144M
+45.1% YoY
Gross Profit
$116M
80.5% margin
Operating Income
$12M
8.4% margin
Net Income
$5M
3.4% margin
EPS (Diluted)
$0.04
QoQ Revenue Growth
+8.5%
Cash Flow
Operating Cash Flow
$53M
Free Cash Flow
$48M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$575M
Stockholders' Equity
$477M
Cash & Equivalents
$246M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$144M
$99M
+45.1%
Gross Profit
$116M
$74M
+55.6%
Operating Income
$12M
$152,000
+7855.3%
Net Income
$5M
$4M
+15.4%
Geographic Segments
UNITED STATES
$98M
71%
GERMANY
$27M
20%
JAPAN
$8M
6%
CHINA
$5M
3%
← FY 2020
All Quarters
Q1 2021 →